Search results

ISSUE NO. 6 — Hybrid Medicines and 505(b)(2) NDA Approval Pathways

Dec 1, 2018

• Regulatory Affairs
• End-to-End Program

ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

Nov 1, 2024

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Bioanalysis

Scientific Publication

Ophthalmic End-to-End Drug Development Solutions

Dec 14, 2022

• Manufacturing and Analytical Services
• End-to-End Program
• Clinical Trials
• Preclinical Research
• Bioanalysis

ISSUE NO. 27 — The Complexities of Early-Phase Ophthalmic Drug Development

Sep 1, 2022

• Manufacturing and Analytical Services
• Preclinical Research
• Clinical Trials
• Bioanalysis
• End-to-End Program

Scientific Publication

One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs

Apr 1, 2022

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Manufacturing and Analytical Services
• Bioanalysis
• CRO Services

Scientific Publication

A Novel Approach for Improved Bioavailability in Solid Dosage Forms

May 30, 2025

• Manufacturing and Analytical Services

ISSUE NO. 33 — End-to-End CNS Drug Development Solutions

Apr 17, 2023

• Manufacturing and Analytical Services
• Preclinical Research
• Clinical Trials
• Bioanalysis
• End-to-End Program